Home/Pipeline/AZT-02 (Cold-adapted Polymerases)

AZT-02 (Cold-adapted Polymerases)

Enhanced NGS & Diagnostics

Platform DevelopmentR&D

Key Facts

Indication
Enhanced NGS & Diagnostics
Phase
Platform Development
Status
R&D
Company

About ArcticZymes Technologies ASA

ArcticZymes Technologies ASA is a public biotech company that develops and commercializes unique enzymes derived from organisms adapted to the extreme cold of the Arctic. Its core technology platform focuses on cold-adapted enzymes, including nucleases, polymerases, and phosphatases, which offer advantages in molecular biology, diagnostics, and next-generation sequencing workflows. The company operates both a product business for research use and a therapeutic discovery pipeline, with strategic partnerships to expand its market reach. Its mission is to translate the unique properties of Arctic biomolecules into innovative tools and potential medicines.

View full company profile